Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art.
cholangiocarcinoma
hepatic arterial infusion chemotherapy
hepatocarcinoma
implanted pump or port
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
21 Jun 2021
21 Jun 2021
Historique:
received:
10
05
2021
revised:
02
06
2021
accepted:
16
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Liver functional failure is one of the leading causes of cancer-related death. Primary liver tumors grow up mainly in the liver, and thus happens for liver metastases deriving from other organs having a lower burden of disease at the primary site. Systemic chemotherapy usually offers a modest benefit in terms of disease control rate, progression-free survival, and overall survival at the cost of a significant percentage of adverse events. Liver malignancies are mostly perfused by the hepatic artery while the normal liver parenchyma by the portal vein network. On these bases, the therapeutic strategy consisting of hepatic arterial infusion (HAI) of chemotherapy takes place. In literature, HAI chemotherapy was applied for the treatment of advanced hepatobiliary cancers with encouraging results. Different chemotherapeutic agents were used such as Oxaliplatin, Cisplatin, Gemcitabine, Floxuridine, 5-Fluorouracil, Epirubicin, individually or in combination. However, the efficacy of this treatment strategy remains controversial. Therefore, this review aims to summarize the current knowledge on this approach from different points of view, such as techniques, drugs pharmacology and pharmacokinetics, and clinical outcomes for advanced hepatobiliary cancers.
Identifiants
pubmed: 34205656
pii: cancers13123091
doi: 10.3390/cancers13123091
pmc: PMC8234226
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Diagn Interv Imaging. 2019 Dec;100(12):753-762
pubmed: 31706790
J Gastroenterol Hepatol. 2020 Aug;35(8):1277-1287
pubmed: 32052876
JAMA Oncol. 2019 Jul 1;5(7):953-960
pubmed: 31070690
Saudi J Anaesth. 2010 Jan;4(1):11-6
pubmed: 20668560
AJR Am J Roentgenol. 2006 Nov;187(5):1312-20
pubmed: 17056922
Semin Oncol. 1983 Jun;10(2):176-82
pubmed: 6346495
J Vasc Interv Radiol. 2005 Apr;16(4):471-6
pubmed: 15802446
Surg Oncol Clin N Am. 2019 Oct;28(4):717-729
pubmed: 31472915
Crit Rev Oncol Hematol. 2011 Oct;80(1):40-53
pubmed: 21067940
Lancet Oncol. 2019 Feb;20(2):282-296
pubmed: 30665869
Cancer. 2005 Apr 1;103(7):1402-7
pubmed: 15726542
Cardiovasc Intervent Radiol. 2001 Mar-Apr;24(2):90-3
pubmed: 11443392
AJR Am J Roentgenol. 1996 Apr;166(4):821-2
pubmed: 8610557
Korean J Radiol. 2016 Sep-Oct;17(5):771-8
pubmed: 27587967
Biosci Trends. 2018;12(1):73-78
pubmed: 29553105
J Vasc Interv Radiol. 2010 Nov;21(11):1681-8
pubmed: 21029950
Surg Today. 2017 Jul;47(7):851-858
pubmed: 28188368
Cardiovasc Intervent Radiol. 1997 Mar-Apr;20(2):128-32
pubmed: 9030504
ESMO Open. 2020 Aug;5(4):
pubmed: 32847838
Cancers (Basel). 2020 Sep 24;12(10):
pubmed: 32987630
Onco Targets Ther. 2016 Dec 12;9:7527-7535
pubmed: 28003766
Recent Results Cancer Res. 1986;100:171-8
pubmed: 2942993
Eur J Cancer. 2009 Sep;45(14):2519-27
pubmed: 19556122
Hepatology. 2001 Jun;33(6):1353-7
pubmed: 11391522
Anticancer Res. 2000 Sep-Oct;20(5A):3259-64
pubmed: 11062751
Oncology. 2011;80(3-4):153-9
pubmed: 21677464
Ann Oncol. 2008 May;19(5):847-51
pubmed: 18029972
ScientificWorldJournal. 2014;2014:160138
pubmed: 24967421
Cancer Res. 1998 Aug 1;58(15):3339-43
pubmed: 9699664
Curr Med Chem. 2012;19(7):938-44
pubmed: 22214462
Eur J Radiol. 2002 Jan;41(1):42-8
pubmed: 11750151
Jpn J Clin Oncol. 2019 Sep 1;49(9):845-855
pubmed: 31063184
J Clin Oncol. 1986 Apr;4(4):596-603
pubmed: 3958769
Hepatol Res. 2014 Nov;44(12):1179-85
pubmed: 24171787
J Vasc Interv Radiol. 2013 Apr;24(4):501-8
pubmed: 23452552
Cancer Chemother Pharmacol. 2018 Sep;82(3):469-478
pubmed: 29982870
Helv Chir Acta. 1989 Jun;56(1-2):127-31
pubmed: 2777591
Pharmacogenomics. 2009 Jun;10(6):931-44
pubmed: 19530960
Hum Vaccin Immunother. 2016 Nov;12(11):2777-2789
pubmed: 27398650
Dig Dis Sci. 2013 Aug;58(8):2399-405
pubmed: 23525734
Ann Surg Oncol. 2014 Oct;21(11):3638-45
pubmed: 24817369
Eur J Cancer. 1995;31A(2):202-8
pubmed: 7718326
Ann Oncol. 2009 Sep;20(9):1589-1595
pubmed: 19491285
Scand J Gastroenterol. 2020 Sep;55(9):1057-1062
pubmed: 32692941
Radiology. 2017 May;283(2):580-589
pubmed: 27820684
Am J Surg. 2003 Jul;186(1):63-6
pubmed: 12842752
J Vasc Interv Radiol. 2018 Mar;29(3):425-431
pubmed: 29402612
Gut Liver. 2021 Mar 15;15(2):284-294
pubmed: 32307975
Diagn Interv Imaging. 2015 Jun;96(6):537-46
pubmed: 24534562
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Cancer. 2016 Mar 1;122(5):758-65
pubmed: 26695839
J Clin Gastroenterol. 2020 Sep;54(8):675-681
pubmed: 32569032
Anticancer Res. 2003 Nov-Dec;23(6D):5203-8
pubmed: 14981990
Oncotarget. 2017 Dec 31;9(8):8197-8203
pubmed: 29487726
Liver Cancer. 2020 Sep;9(5):583-595
pubmed: 33083282
Clin Radiol. 1999 Apr;54(4):221-7
pubmed: 10210340
Oncology. 2018;94(4):215-222
pubmed: 29428943
J Natl Cancer Inst. 2020 Feb 1;112(2):200-210
pubmed: 31077311
Lancet Oncol. 2014 Jul;15(8):819-28
pubmed: 24852116
Lancet. 2016 Jul 30;388(10043):518-29
pubmed: 26853587
Cardiovasc Intervent Radiol. 2018 May;41(5):734-743
pubmed: 29327075
Lancet. 2017 Jan 7;389(10064):56-66
pubmed: 27932229
Angiology. 1990 Nov;41(11):936-41
pubmed: 2244698
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432
pubmed: 29631810
Updates Surg. 2015 Dec;67(4):389-400
pubmed: 26468142
BMC Cancer. 2019 Oct 15;19(1):954
pubmed: 31615466
Diagn Interv Imaging. 2020 Jul - Aug;101(7-8):439-449
pubmed: 32035822
In Vivo. 2009 Sep-Oct;23(5):813-20
pubmed: 19779117
Cancer Genomics Proteomics. 2013 Mar-Apr;10(2):89-92
pubmed: 23603345
J Clin Oncol. 2017 Jun 10;35(17):1938-1944
pubmed: 28426374
World J Gastroenterol. 2004 Jun 1;10(11):1659-62
pubmed: 15162545
Pain Manag. 2017 Nov;7(6):523-535
pubmed: 29125398
AJR Am J Roentgenol. 2002 Dec;179(6):1611-7
pubmed: 12438064
Cardiovasc Intervent Radiol. 2001 Jan-Feb;24(1):31-6
pubmed: 11178710
Pharmacogenomics J. 2019 Dec;19(6):556-563
pubmed: 30723313
Nihon Yakurigaku Zasshi. 2019;153(5):242-248
pubmed: 31092758
World J Gastroenterol. 2015 May 21;21(19):6018-25
pubmed: 26019468
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7764-7775
pubmed: 32744703
Lancet Oncol. 2015 Dec;16(16):1639-50
pubmed: 26603945
Radiology. 2000 Apr;215(1):294-9
pubmed: 10751501
J Vasc Interv Radiol. 2003 Jan;14(1):63-8
pubmed: 12525587
J Clin Oncol. 2010 Jul 20;28(21):3531-40
pubmed: 20547994
J Hepatol. 2018 Jul;69(1):60-69
pubmed: 29471013
J Dig Dis. 2015 Sep;16(9):505-12
pubmed: 26121102
Br J Radiol. 2002 Oct;75(898):799-804
pubmed: 12381688
Diagnostics (Basel). 2021 Feb 26;11(3):
pubmed: 33652814
Anticancer Res. 2007 Jul-Aug;27(4C):3009-13
pubmed: 17695488
JAMA Oncol. 2020 Jan 1;6(1):60-67
pubmed: 31670750
Radiology. 1980 May;135(2):295-9
pubmed: 7367615
World J Gastroenterol. 2014 Jan 14;20(2):486-97
pubmed: 24574717
Lancet Oncol. 2015 Jul;16(7):859-70
pubmed: 26095784
Am J Clin Oncol. 2011 Feb;34(1):58-62
pubmed: 20177362
Radiology. 1997 Feb;202(2):574-7
pubmed: 9015093
J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):181-5
pubmed: 16767928
J Vasc Interv Radiol. 1998 Mar-Apr;9(2):233-9
pubmed: 9540905
J Clin Oncol. 1983 Dec;1(12):755-62
pubmed: 6321676
J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):203-6
pubmed: 16767932
Int J Mol Sci. 2021 Feb 17;22(4):
pubmed: 33671327
Eur J Radiol. 2013 Oct;82(10):1665-71
pubmed: 23743053
Med J Aust. 2016 May 2;204(8):315-7
pubmed: 27125806
Gan To Kagaku Ryoho. 1992 Jul;19(7):1007-13
pubmed: 1626936
Chemotherapy. 2013;59(5):354-60
pubmed: 24821200
Am J Roentgenol Radium Ther Nucl Med. 1973 Mar;117(3):696-700
pubmed: 4511885
Ann Oncol. 2001 May;12(5):599-603
pubmed: 11432616
Curr Drug Metab. 2009 Jun;10(5):470-81
pubmed: 19689244
Cancers (Basel). 2019 Jan 24;11(2):
pubmed: 30682873
Pain Med. 2013 Jan;14(1):124-44
pubmed: 23241132
J Oncol Pharm Pract. 2017 Oct;23(7):525-539
pubmed: 27306885